Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Skin ageing-General features of facial ageing and therapeutic choices].

Annales de dermatologie et de venereologie·2018
Same author

[Post-inflammatory hyperpigmentation occuring after cosmetic procedures].

Annales de dermatologie et de venereologie·2018
Same author

Propionibacterium acnes: an update on its role in the pathogenesis of acne.

Journal of the European Academy of Dermatology and Venereology : JEADV·2013
Same author

[Algorithm for treatment of juvenile facial acne].

Annales de dermatologie et de venereologie·2011
Same author

Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe.

Journal of the European Academy of Dermatology and Venereology : JEADV·2010
Same author

[Skin aging: clinicopathological features and mechanisms].

Annales de dermatologie et de venereologie·2009

Related Experiment Video

Updated: Jun 21, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

[Different botulinum toxins and their specifications].

C Beylot1

  • 1Université Victor Segalen Bordeaux 2, 101, boulevard Wilson, 33200 Bordeaux. claire.beylot@wanadoo.fr

Annales De Dermatologie Et De Venereologie
|July 7, 2009
PubMed
Summary

Botulinum neurotoxin A products like Botox and Dysport have different units due to manufacturing variations. Current cosmetic use trends favor lower Dysport to Botox conversion ratios for economic reasons.

Area of Science:

  • Neurology
  • Dermatology
  • Cosmetic Science

Context:

  • Botulinum neurotoxin A, initially developed for therapeutic uses, is now widely applied in esthetic medicine.
  • Key commercial formulations include Botox and Dysport, which exhibit distinct physicochemical properties.
  • Differences in manufacturing, including excipient content and protein complex size, contribute to their non-equivalence in units.

Purpose:

  • To elucidate the differences between Botulinum neurotoxin A formulations, specifically Botox and Dysport.
  • To analyze the factors contributing to their unit non-equivalence and varying diffusion characteristics.
  • To review the evolution of conversion ratios between these neurotoxins, particularly for cosmetic applications.

Summary:

  • Botox and Dysport differ in molecular complex size (900 kDa vs. 500 kDa) and excipient composition, impacting their diffusion profiles.

More Related Videos

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

Related Experiment Videos

Last Updated: Jun 21, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

  • Clinical studies, despite methodological limitations, have suggested conversion ratios that have shifted over time.
  • Early neurological and ophthalmological applications used higher ratios (4:1), while current cosmetic indications trend towards lower ratios (2.5:1).
  • Impact:

    • The shift towards lower Dysport to Botox ratios in cosmetic applications has significant economic implications, making Dysport more competitive.
    • Understanding these differences is crucial for accurate dosing and achieving desired clinical outcomes in esthetic treatments.
    • Further research with robust methodologies is needed to definitively establish optimal conversion ratios and understand diffusion dynamics.